IBDEI0FJ ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,6853,1,4,0)
 ;;=4^L60.3
 ;;^UTILITY(U,$J,358.3,6853,2)
 ;;=^5009236
 ;;^UTILITY(U,$J,358.3,6854,0)
 ;;=L92.1^^46^452^4
 ;;^UTILITY(U,$J,358.3,6854,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6854,1,3,0)
 ;;=3^Necrobiosis Lipoidica NEC
 ;;^UTILITY(U,$J,358.3,6854,1,4,0)
 ;;=4^L92.1
 ;;^UTILITY(U,$J,358.3,6854,2)
 ;;=^5009462
 ;;^UTILITY(U,$J,358.3,6855,0)
 ;;=L20.81^^46^452^7
 ;;^UTILITY(U,$J,358.3,6855,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6855,1,3,0)
 ;;=3^Neurodermatitis,Atopic
 ;;^UTILITY(U,$J,358.3,6855,1,4,0)
 ;;=4^L20.81
 ;;^UTILITY(U,$J,358.3,6855,2)
 ;;=^5009108
 ;;^UTILITY(U,$J,358.3,6856,0)
 ;;=D48.5^^46^452^6
 ;;^UTILITY(U,$J,358.3,6856,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6856,1,3,0)
 ;;=3^Neoplasm,Skin,Uncertain Behavior
 ;;^UTILITY(U,$J,358.3,6856,1,4,0)
 ;;=4^D48.5
 ;;^UTILITY(U,$J,358.3,6856,2)
 ;;=^267777
 ;;^UTILITY(U,$J,358.3,6857,0)
 ;;=D49.2^^46^452^5
 ;;^UTILITY(U,$J,358.3,6857,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6857,1,3,0)
 ;;=3^Neoplasm,Bone/Soft Tissue/Skin,Unspec Behavior
 ;;^UTILITY(U,$J,358.3,6857,1,4,0)
 ;;=4^D49.2
 ;;^UTILITY(U,$J,358.3,6857,2)
 ;;=^5002272
 ;;^UTILITY(U,$J,358.3,6858,0)
 ;;=L60.0^^46^452^3
 ;;^UTILITY(U,$J,358.3,6858,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6858,1,3,0)
 ;;=3^Nail,Ingrowing
 ;;^UTILITY(U,$J,358.3,6858,1,4,0)
 ;;=4^L60.0
 ;;^UTILITY(U,$J,358.3,6858,2)
 ;;=^5009234
 ;;^UTILITY(U,$J,358.3,6859,0)
 ;;=L60.9^^46^452^1
 ;;^UTILITY(U,$J,358.3,6859,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6859,1,3,0)
 ;;=3^Nail Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,6859,1,4,0)
 ;;=4^L60.9
 ;;^UTILITY(U,$J,358.3,6859,2)
 ;;=^5009240
 ;;^UTILITY(U,$J,358.3,6860,0)
 ;;=Z91.19^^46^452^9
 ;;^UTILITY(U,$J,358.3,6860,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6860,1,3,0)
 ;;=3^Noncompliance w/ Medical Treatment/Regimen
 ;;^UTILITY(U,$J,358.3,6860,1,4,0)
 ;;=4^Z91.19
 ;;^UTILITY(U,$J,358.3,6860,2)
 ;;=^5063618
 ;;^UTILITY(U,$J,358.3,6861,0)
 ;;=E80.1^^46^453^19
 ;;^UTILITY(U,$J,358.3,6861,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6861,1,3,0)
 ;;=3^Porphyria Cutanea Tarda
 ;;^UTILITY(U,$J,358.3,6861,1,4,0)
 ;;=4^E80.1
 ;;^UTILITY(U,$J,358.3,6861,2)
 ;;=^5002982
 ;;^UTILITY(U,$J,358.3,6862,0)
 ;;=L56.4^^46^453^18
 ;;^UTILITY(U,$J,358.3,6862,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6862,1,3,0)
 ;;=3^Polymorphous Light Eruption
 ;;^UTILITY(U,$J,358.3,6862,1,4,0)
 ;;=4^L56.4
 ;;^UTILITY(U,$J,358.3,6862,2)
 ;;=^5009218
 ;;^UTILITY(U,$J,358.3,6863,0)
 ;;=L10.0^^46^453^4
 ;;^UTILITY(U,$J,358.3,6863,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6863,1,3,0)
 ;;=3^Pemphigus Vulgaris
 ;;^UTILITY(U,$J,358.3,6863,1,4,0)
 ;;=4^L10.0
 ;;^UTILITY(U,$J,358.3,6863,2)
 ;;=^91129
 ;;^UTILITY(U,$J,358.3,6864,0)
 ;;=L41.3^^46^453^2
 ;;^UTILITY(U,$J,358.3,6864,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6864,1,3,0)
 ;;=3^Parapsoriasis,Small Plague
 ;;^UTILITY(U,$J,358.3,6864,1,4,0)
 ;;=4^L41.3
 ;;^UTILITY(U,$J,358.3,6864,2)
 ;;=^5009173
 ;;^UTILITY(U,$J,358.3,6865,0)
 ;;=L41.4^^46^453^1
 ;;^UTILITY(U,$J,358.3,6865,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6865,1,3,0)
 ;;=3^Parapsoriasis,Large Plague
 ;;^UTILITY(U,$J,358.3,6865,1,4,0)
 ;;=4^L41.4
 ;;^UTILITY(U,$J,358.3,6865,2)
 ;;=^5009174
 ;;^UTILITY(U,$J,358.3,6866,0)
 ;;=L28.1^^46^453^29
 ;;^UTILITY(U,$J,358.3,6866,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6866,1,3,0)
 ;;=3^Prurigo Nodularis
 ;;^UTILITY(U,$J,358.3,6866,1,4,0)
 ;;=4^L28.1
 ;;^UTILITY(U,$J,358.3,6866,2)
 ;;=^5009148
 ;;^UTILITY(U,$J,358.3,6867,0)
 ;;=H61.001^^46^453^6
 ;;^UTILITY(U,$J,358.3,6867,1,0)
 ;;=^358.31IA^4^2
